Conmed Corp (CNMD)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

525 FRENCH ROAD UTICA, NY 13502

Conmed is a medical technology company which focuses on surgical devices and equipment for minimally invasive procedures and monitoring. Co. conducts its business through five segments: CONMED Endosurgery, CONMED Electrosurgery and CONMED Linvatec, all of which provide a line of endo-mechanical instrumentation for minimally invasive laparoscopic procedures, electrosurgical generators and related instruments, and arthroscopic instrumentation for use in orthopedic surgery; CONMED Patient Care, which includes a line of vital signs and cardiac monitoring products; and CONMED Endoscopic Technologies, which provides a line of minimally invasive endoscopic diagnostic and therapeutic instruments.

Data as of 2020-09-12
Market Cap2.531 Billion Shares Outstanding28.571 Million Avg 30-day Volume241.324 Thousand
P/E Ratio Dividend Yield0.903 EPS-0.03
Price/Sales2.909 Price cash flow ratio29.7 Price free cash flow ratio63.3
Book Value23.62 Price to Tangible Book-5.5 Alpha0.0
Short Interest Ratio6.0 % Short Interest to Float6.0 R-squared0.278563
BETA1.22568 52-week High/Low116.81 / 37.66 Stddev0.099226
View SEC Filings from CNMD instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 0 1 (0.07%) 0 (0.0%)
Funds Holding: 226 231 -2.16% 64 (4.17%) 65 (4.16%) -1.54%
13F shares: 29.205 Million 29.11 Million 0.33% 7.749 Million 7.861 Million -1.42%
% Ownership 27.1227 27.5557 -1.57%
New Positions: 35 33 6.06% 16 9 77.78%
Increased Positions 78 96 -18.75% 19 35 -45.71%
Closed Positions 38 66 -42.42% 17 22 -22.73%
Reduced Positions 77 75 2.67% 22 19 15.79%
Total Calls 81.561 Thousand 39.157 Thousand 108.29% 58.8 Thousand 16.2 Thousand 262.96%
Total Puts 69.202 Thousand 62.7 Thousand 10.37% 20 Thousand 18.9 Thousand 5.82%
PUT/CALL Ratio 0.85 1.6 -46.88% 0.34 1.17 -70.94%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CNMD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CNMD BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

16 Thousand total shares from 4 transactions

Exercise Derivative Conversion (M)

9.5 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SCHWARZENTRAUB BARBARA J

  • Director
895 2020-09-23 2

CONCANNON BRIAN

  • Director
13,906 2020-09-10 2

SHAGORY PETER K EVP, STRAT & CORP DEVT

  • Officer
1,861 2020-09-04 5

JONAS DANIEL EVP LEGAL AFFAIRS,GEN. COUNSEL

  • Officer
12,880 2020-07-31 4

RUIZ-CABAN WILFREDO EVP QA, RA AND OPERATIONS

  • Officer
3,975 2020-06-30 6

TRYNISKI MARK E

  • Director
42,889 2020-06-01 2

LANDE JEROME J.

  • Director
8,407 2020-06-01 1

FARKAS CHARLES

  • Director
16,910 2020-06-01 1

WORKMAN JOHN L

  • Director
17,442 2020-06-01 2

BRONSON DAVID M

  • Director
12,442 2020-06-01 1

ARONSON MARTHA GOLDBERG

  • Director
8,942 2020-06-01 1

PELLETIER JOHONNA MARIE TREASURER AND VP, TAX

  • Officer
3,881 2020-06-01 2

COUNCIL LAVERNE H

  • Director
0 2020-06-01 3

COHEN HEATHER L EVP CORP HR

  • Officer
19,328 2020-05-18 4

PETERS STANLEY W III VP GM ADVANCED SURGERY

  • Officer
563 2020-03-31 6

GARNER TODD W. EXECUTIVE VICE PRESIDENT & CFO

  • Officer
3,529 2020-03-31 3

HARTMAN CURT R PRESIDENT & CEO

  • Officer
  • Director
104,051 2020-02-28 2

BEYER PAT PRESIDENT - INTERNATIONAL

  • Officer
7,807 2020-02-28 1

BERGE TERENCE M VP-CORPORATE CONTROLLER

  • Officer
20,035 2020-02-28 1

KENNEDY JOHN JED VP GM CET

  • Officer
5,609 2020-02-28 5

FOLKERT NATHAN VP GM ORTHOPEDICS

  • Officer
2,280 2020-02-28 1

KUYPER DIRK

  • Director
5,000 2019-08-01 0

GOLDEN JO ANN

  • Director
No longer subject to file 2018-06-01 0

POMILIO LUKE A

  • ADVISOR TO CFO
No longer subject to file 2018-03-01 0

SNYDER MARK D EVP MFG. OPS & BUSINESS SYSTEM

  • Officer
No longer subject to file 2016-03-31 0

JONES GREGORY RENARD EVP-CORPORATE QA/RA

  • Officer
No longer subject to file 2015-09-30 0

MANDIA STEPHEN

  • Director
No longer subject to file 2015-05-29 0

SHALLISH ROBERT D JR EVP, FINANCE, CFO

  • Officer
No longer subject to file 2015-03-31 0

DARLING JOSEPH G EVP, COMMERCIAL OPERATIONS

  • Officer
No longer subject to file 2015-02-02 0

ABRAHAM WILLIAM EVP-BUSINESS DEVELOPMENT

  • Officer
No longer subject to file 2014-09-30 0

DANIELS BRUCE

  • Director
5,000 2014-07-30 0

CORASANTI JOSEPH J FORMER PRESIDENT & CEO

  • Officer
No longer subject to file 2014-07-30 0

CORASANTI EUGENE R

  • Director
No longer subject to file 2014-07-23 0

SCHWARTZ STUART J

  • Director
10,600 2014-06-01 0

JOHNSON DAVID ALLEN VP - GLOBAL OPERATIONS

  • Officer
468 2010-02-25 0

METCALF JANE E VP CORPORATE REG. AFFAIRS

  • Officer
No longer subject to file 2008-12-31 0

MURRAY DAVID R PRESIDENT ELECTROSURGERY

  • Officer
No longer subject to file 2008-12-31 0

MATTHEWS WILLIAM

  • Director
No longer subject to file 2008-05-19 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SCHWARZENTRAUB BARBARA J - Director

2020-09-25 11:55:45 -0400 2020-09-23 M 895 a 895 direct

SCHWARZENTRAUB BARBARA J - Director

2020-09-25 11:55:45 -0400 2020-09-23 M 895 d 0 direct

CONCANNON BRIAN - Director

2020-09-14 16:10:07 -0400 2020-09-10 S 3,036 $89.31 d 13,906 direct -1.5714 -12.0824 0.0 1 -14.6898 5

SHAGORY PETER K - Officer EVP, STRAT & CORP DEVT

2020-09-08 14:39:50 -0400 2020-09-04 S 4,200 $85.88 d 1,861 direct 4.2972 1.3764 4.2972 2 0.0 1

SHAGORY PETER K - Officer EVP, STRAT & CORP DEVT

2020-09-08 14:39:50 -0400 2020-09-04 M 4,200 $41.93 a 6,061 direct 4.2972 1.3764 4.2972 2 0.0 1

SHAGORY PETER K - Officer EVP, STRAT & CORP DEVT

2020-09-08 14:39:50 -0400 2020-09-04 M 4,200 d 18,300 direct

SHAGORY PETER K - Officer EVP, STRAT & CORP DEVT

2020-08-03 17:13:10 -0400 2020-07-31 M 4,440 $39.87 a 6,301 direct 1.7235 4.3088 2.8716 8.2656 22 -0.6797 14

JONAS DANIEL - Officer EVP LEGAL AFFAIRS,GEN. COUNSEL daughter

2020-08-03 16:12:35 -0400 2020-07-31 G 100 a 300 indirect 1.7235 4.3088 2.8716 8.2656 22 -0.6797 14

SHAGORY PETER K - Officer EVP, STRAT & CORP DEVT

2020-08-03 17:13:10 -0400 2020-07-31 M 4,440 d 4,440 direct

JONAS DANIEL - Officer EVP LEGAL AFFAIRS,GEN. COUNSEL

2020-08-03 16:12:35 -0400 2020-07-31 G 100 d 13,180 direct 1.7235 4.3088 2.8716 8.2656 22 -0.6797 14

SHAGORY PETER K - Officer EVP, STRAT & CORP DEVT

2020-08-03 17:13:10 -0400 2020-07-31 S 4,440 $84.57 d 1,861 direct 1.7235 4.3088 2.8716 8.2656 22 -0.6797 14

JONAS DANIEL - Officer EVP LEGAL AFFAIRS,GEN. COUNSEL

2020-08-03 16:12:35 -0400 2020-07-31 G 600 d 12,580 direct 1.7235 4.3088 2.8716 8.2656 22 -0.6797 14

JONAS DANIEL - Officer EVP LEGAL AFFAIRS,GEN. COUNSEL

2020-08-03 16:12:35 -0400 2020-07-31 S 4,349 $82.66 d 13,280 direct 1.7235 4.3088 2.8716 8.2656 22 -0.6797 14

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments